ChemoCentryx, Inc. (CCXI): $49.03

-0.38 (-0.77%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add CCXI to Watchlist
Sign Up

Industry: Biotech


Ranked

of 491

in industry

ChemoCentryx Inc (CCXI) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering CCXI.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
8 $120 $70 $88.88 $48 85.17%

The Trend in the Analyst Price Target


CCXI's average price target has moved up $12.26 over the prior 146 days.

Over the past 295 days, CCXI's average upside potential has been 37.53%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2020-06-01 7 95 64 73.86 60.96 21.16%
2020-06-12 8 95 64 73.38 65.07 12.77%
2020-07-29 8 95 61 73.00 52.65 38.65%
2020-08-15 8 100 63 75.62 52.64 43.66%
2020-09-16 8 100 63 76.75 53.68 42.98%
2020-10-28 8 100 60 76.62 52.24 46.67%
2020-11-05 7 100 60 77.57 54.57 42.15%
2020-11-23 8 100 60 76.63 57.28 33.78%
2020-12-19 8 100 60 76.63 60.69 26.26%
2020-12-26 8 100 60 78.25 60.55 29.23%
2021-01-02 8 100 60 78.25 61.92 26.37%
2021-01-09 8 119 60 80.63 62.78 28.43%
2021-01-16 8 119 60 80.63 62.02 30.01%
2021-01-23 8 119 60 80.63 64.40 25.2%
2021-01-28 8 119 60 80.63 57.12 41.16%
2021-03-05 8 120 70 88.88 57.24 55.28%
2021-03-13 8 120 70 88.88 57.66 54.14%
2021-03-20 8 120 70 88.88 58.12 52.92%
2021-03-23 8 120 70 88.88 54.76 62.31%

CCXI Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.31 4 3 1 0 0 8

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CCXI as an investment opportunity.

  • CCXI has a higher upside potential (average analyst target price relative to current price) than 84.55% of all US stocks.
  • ChemoCentryx Inc's average analyst price target is greater than 82.69% of all US stocks.
  • ChemoCentryx Inc's variance in analysts' estimates is lower than 20.51% of stocks in the mid market cap category.
  • ChemoCentryx Inc's number of analysts covering the stock is greater than 76.1% of Pharmaceutical Products stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ChemoCentryx Inc are ORIC, ALBO and YMAB.

What is the outlook for CCXI? Use POWR Ratings for clearer insight into price direction.



Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8811 seconds.